Direxion Daily S&P 500 High Beta Bull 3X ETF (HIBL)

NYSEARCA: HIBL · Real-Time Price · USD
97.81
+4.79 (5.15%)
At close: May 5, 2026, 4:00 PM EDT
104.52
+6.71 (6.86%)
Pre-market: May 6, 2026, 7:38 AM EDT
Assets$80.31M
Expense Ratio0.98%
PE Ration/a
Shares Out864,371
Dividend (ttm)$1.59
Dividend Yield1.63%
Ex-Dividend DateDec 10, 2025
Payout FrequencySemi-Annual
Payout Ration/a
Volume57,871
Open95.53
Previous Close93.02
Day's Range95.05 - 98.30
52-Week Low24.89
52-Week High98.30
Beta4.25
Holdings112
Inception DateNov 7, 2019

About HIBL

Fund Home Page

The Direxion Daily S&P 500 High Beta Bull 3X ETF (HIBL) is an exchange-traded fund that is based on the S&P 500 High Beta index. The fund provides 3x daily leveraged exposure to a beta-weighted index of 100 highest-beta stocks in the S&P 500. HIBL was launched on Nov 7, 2019 and is issued by Direxion.

Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol HIBL
ETF Provider Direxion
Index Tracked S&P 500 High Beta Index

Top 10 Holdings

69.46% of assets
NameSymbolWeight
Dreyfus Govt Cash Man Insn/a23.92%
S&P 500 High Beta Index Swapn/a14.34%
Goldman Finl Sq Trsry Inst 506n/a8.45%
S&P 500 High Beta Index Swapn/a7.43%
S&P 500 High Beta Index Swapn/a5.77%
Goldman Sachs Fin Gov 465 Institutn/a4.35%
S&P 500 High Beta Index Swapn/a1.82%
Advanced Micro Devices, Inc.AMD1.16%
Micron Technology, Inc.MU1.11%
Dell Technologies Inc.DELL1.10%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 10, 2025$1.41267Dec 17, 2025
Jun 24, 2025$0.10611Jul 1, 2025
Mar 25, 2025$0.07521Apr 1, 2025
Sep 24, 2024$0.06582Oct 1, 2024
Jun 25, 2024$0.12232Jul 2, 2024
Mar 19, 2024$0.15426Mar 26, 2024
Full Dividend History

Performance

HIBL had a total return of 276.12% in the past year, including dividends. Since the fund's inception, the average annual return has been 17.21%.

News

An Opportunity To Leverage Volatility In Unexpected Industries

Given the momentum of the previous 12 months and the fact that the threat of COVID-19 has seemingly begun to recede in many parts of the world, including the U.S., traders may have been hoping 2021 wo...

5 years ago - Benzinga